[go: up one dir, main page]

MXPA04000382A - Proceso para preparacion de l-ribavirina. - Google Patents

Proceso para preparacion de l-ribavirina.

Info

Publication number
MXPA04000382A
MXPA04000382A MXPA04000382A MXPA04000382A MXPA04000382A MX PA04000382 A MXPA04000382 A MX PA04000382A MX PA04000382 A MXPA04000382 A MX PA04000382A MX PA04000382 A MXPA04000382 A MX PA04000382A MX PA04000382 A MXPA04000382 A MX PA04000382A
Authority
MX
Mexico
Prior art keywords
ribavirin
formula
preparation
reaction
group
Prior art date
Application number
MXPA04000382A
Other languages
English (en)
Inventor
Mancini Alfredo
Original Assignee
Clariant Lsm Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant Lsm Italia Spa filed Critical Clariant Lsm Italia Spa
Publication of MXPA04000382A publication Critical patent/MXPA04000382A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056Triazole or tetrazole radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)

Abstract

Se describe un proceso para la preparacion de L-ribavirina a escala industrial que comprende la reaccion de glicosilacion de 3 triazoles sustituidos en presencia de un acido de Lewis y de un solvente. El proceso comprende: a)la reaccion de un triazol de formula (ver formula) con una L-ribofuranosa protegida de formula (ver formula) b) la eliminacion de los grupos Pg y opcionalmente, la conversion en un grupo carboxiamida del grupo R2 del compuesto obtenido de formula (ver formula) para dar L-ribavirina.
MXPA04000382A 2001-07-30 2002-07-25 Proceso para preparacion de l-ribavirina. MXPA04000382A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01830510A EP1281715B1 (en) 2001-07-30 2001-07-30 Process for the preparation of ribavirin
PCT/EP2002/008330 WO2003011883A2 (en) 2001-07-30 2002-07-25 Process for the preparation of l-ribavirin

Publications (1)

Publication Number Publication Date
MXPA04000382A true MXPA04000382A (es) 2004-07-23

Family

ID=8184638

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA04000382A MXPA04000382A (es) 2001-07-30 2002-07-25 Proceso para preparacion de l-ribavirina.
MXPA03010251A MXPA03010251A (es) 2001-07-30 2002-07-29 Proceso para la preparacion de ribavirina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MXPA03010251A MXPA03010251A (es) 2001-07-30 2002-07-29 Proceso para la preparacion de ribavirina.

Country Status (13)

Country Link
US (2) US7285660B2 (es)
EP (2) EP1281715B1 (es)
JP (2) JP2004538317A (es)
KR (2) KR20040031784A (es)
CN (2) CN1255420C (es)
AT (2) ATE252594T1 (es)
AU (1) AU2002328974A1 (es)
BR (2) BR0210278A (es)
DE (2) DE60101056T2 (es)
ES (2) ES2208540T3 (es)
HU (2) HUP0401615A2 (es)
MX (2) MXPA04000382A (es)
WO (2) WO2003011883A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003253380A1 (en) * 2002-08-12 2004-03-11 F. Hoffmann-La-Roche Ag Process for producing a ribofuranose
EP1904071A2 (en) * 2005-07-08 2008-04-02 Aurobindo Pharma Limited Compositions of antiviral compound
JP2008222630A (ja) * 2007-03-12 2008-09-25 Permachem Asia Ltd 1−β−D−リボフラノシルー1,2,4−トリアゾール−3−カルボキサミドのR−II型結晶の製造法
CN101891786B (zh) * 2010-08-04 2012-09-05 王明 一种利巴韦林化合物及其制法
CA2818853A1 (en) 2010-11-30 2012-06-07 Gilead Pharmasset Llc 2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
CN102127134B (zh) * 2010-12-02 2012-11-14 海南美兰史克制药有限公司 一种利巴韦林化合物及其方法
CN102532226B (zh) * 2010-12-15 2014-05-07 上海迪赛诺医药发展有限公司 利巴韦林晶型及其制备方法
CN109134565A (zh) * 2017-08-15 2019-01-04 李双喜 一种1/10水利巴韦林化合物及其药物组合物
CN109134566A (zh) * 2017-08-18 2019-01-04 樊艳芳 一种1/20水利巴韦林化合物
CN108484691A (zh) * 2018-06-28 2018-09-04 牡丹江师范学院 一种利巴韦林缩合物的化学合成方法
CN111647033A (zh) * 2020-06-08 2020-09-11 济南明鑫制药股份有限公司 一锅法制备利巴韦林的方法
CN115322236A (zh) * 2022-09-06 2022-11-11 启东东岳药业有限公司 合成利巴韦林的新方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
JPS55160793A (en) * 1979-05-29 1980-12-13 Microbial Chem Res Found Preparation of virazole
JPS5931797A (ja) * 1982-08-18 1984-02-20 Sumitomo Chem Co Ltd 新規1−置換イミダゾ−ルヌクレオシドおよびその製造法
JPS60252493A (ja) * 1984-05-25 1985-12-13 Takeda Chem Ind Ltd シチジン誘導体の製造法
FI881413L (fi) * 1987-03-25 1988-09-26 Wellcome Found Foerfarande foer framstaellning av 3'-azido-3'-deoxitymidin.
CN1049435C (zh) * 1994-11-09 2000-02-16 中国科学院上海药物研究所 含苯基和杂环基的青蒿素衍生物及其制备方法
EP1132393B1 (en) * 1996-10-16 2003-04-09 ICN Pharmaceuticals, Inc. L-Ribavirin and uses thereof
ES2195970T3 (es) * 1996-10-16 2003-12-16 Ribapharm Inc L-ribavirina y usos de la misma.

Also Published As

Publication number Publication date
AU2002328974A1 (en) 2003-02-17
ES2208540T3 (es) 2004-06-16
KR20040021670A (ko) 2004-03-10
HUP0401899A2 (hu) 2004-12-28
WO2003011883A3 (en) 2003-04-17
ATE286062T1 (de) 2005-01-15
WO2003011883A2 (en) 2003-02-13
ES2233857T3 (es) 2005-06-16
US7285659B2 (en) 2007-10-23
KR100953031B1 (ko) 2010-04-14
US20040192904A1 (en) 2004-09-30
MXPA03010251A (es) 2004-03-16
DE60101056D1 (de) 2003-11-27
EP1414836B1 (en) 2004-12-29
EP1281715A1 (en) 2003-02-05
DE60202483D1 (de) 2005-02-03
EP1414836A2 (en) 2004-05-06
DE60202483T2 (de) 2005-12-29
CN1255420C (zh) 2006-05-10
BR0210278A (pt) 2004-07-20
CN1535277A (zh) 2004-10-06
US20040176587A1 (en) 2004-09-09
JP2004538318A (ja) 2004-12-24
ATE252594T1 (de) 2003-11-15
DE60101056T2 (de) 2004-05-19
CN1535278A (zh) 2004-10-06
WO2003011884A1 (en) 2003-02-13
HUP0401615A2 (hu) 2004-11-29
JP2004538317A (ja) 2004-12-24
KR20040031784A (ko) 2004-04-13
CN1255421C (zh) 2006-05-10
EP1281715B1 (en) 2003-10-22
BR0209815A (pt) 2004-06-01
US7285660B2 (en) 2007-10-23

Similar Documents

Publication Publication Date Title
AUPO903897A0 (en) Organic boronic acid derivatives
MXPA04000382A (es) Proceso para preparacion de l-ribavirina.
EP0654517A3 (de) Umsetzungsprodukte aus einer Aluminiumverbindung, einer Bor enthaltenden Säure, einer Phosphor enthaltenden Säure und eines Amins.
PL353539A1 (en) N-heterocyclic derivatives as NOS inhibitors
IN2001CH00173A (es)
AU2003228678A1 (en) 1-substituted imidazole derivatives as nos inhibitors
CA2362217A1 (en) Process for preparing phenylpyrazole pesticidal intermediates
EP1085015A3 (en) Catalyst comprising a nitrogen-containing heterocylic compound
AU2905702A (en) Cyclization process step in the making of quinolones and naphthyridines
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
NZ513551A (en) Novel process for preparing alendronic acid
IL148161A0 (en) Process for the preparation of 2-cyanopyridines
ZA200005110B (en) Process for preparing intermediates.
CA2131474A1 (en) Preparation of hydroxyoxaalkylmelamines
IL136739A (en) Diol compounds and processes for their preparation
TNSN04084A1 (en) Process for reacting alkaloids and use of the reaction products in the preparation of medicaments
CA2366600A1 (en) A process for the preparation of 1,4,7,10-tetraazacyclododecane
IL141284A0 (en) Process for the production of n-protected azetidine-2-carboxylic acids (azeohs)
CA2364862A1 (en) Process for preparing derivatives of biphenyl-2-carboxylic acid
AU2003236339A1 (en) Novel polyether compound containing acid group and unsaturated group, process for producing the same, and resin composition
MY133826A (en) Process for the preparation of trimethylolpropane caprylate/caprate
HUP0201574A2 (en) Process for the preparation of fumagillin
MXPA04004708A (es) Proceso para preparacion de 2- o 9-oxa-3,7-diazabiciclo (3.3.1)nonanos a partir de 2-aminometil-2,3-dihidrooxazinas, compuestos intermedios para los mismos y proceso para preparar tales compuestos intermedios.
AU2003250876A1 (en) Hydroxylation process for aromatic compounds containing a dioxa- heterocyclic system
UA56831C2 (uk) Похідні 1,4-дигідропіридину та спосіб їх одержання

Legal Events

Date Code Title Description
FG Grant or registration